arrow
A

Akram Khan

oregon health & science university
H指数:56
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of immunization information systems, electronic medical records, and self-report to ascertain RSV vaccination status among US adults aged ≥60 years, 2023–2024

比较免疫接种信息系统、电子病历和自我报告以确定2023–2024年美国≥60岁成年人RSV疫苗接种状况

Vaccine
IF3.5
2025-11-220
PRE
Association Between Operator Experience and Procedural Outcomes of Tracheal Intubation in the Emergency Department and ICU

急诊科和ICU气管插管操作结果与操作者经验之间的关系

2025-08-230
PRE
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus

成人呼吸道合胞病毒感染的多重共病模式与院内严重预后

2025-08-010
PRE
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024

疫苗对流感A(H1N1)、A(H3N2)和B相关住院的效力,美国,2023年9月1日至2024年5月31日

2025-04-080
PRE
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination

与呼吸道合胞病毒疫苗接种相关的患者层面和社区层面特征

2025-04-010
OA
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19

二肽基peptidase-3和肾素 (SPiDeR) 在新型冠状病毒肺炎低氧血症患者中的休克预测

2025-02-010
PRE
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United 2019-2022

2019-2022年美国住院成人中COVID-19和流感疫苗犹豫现象

VACCINE
IF3.5
2025-02-010
PRE
Sex differences in global electrical heterogeneity: The Hispanic Community Health Study/Study of Latinos

全球电学异质性的性别差异:Hispanic Community Health Study/Study of Latinos

2025-01-010
OAAI
Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials
2025-01-010
OAAI
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study

早期奥司他韦治疗对甲型流感住院成人患者的益处: 一项观察性研究

2024-11-281
OA
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023

2022年9月-2023年8月,原始单价和二价新型冠状病毒肺炎疫苗对美国成人COVID-19-Associated住院和严重住院结局的有效性

2024-11-040
OA
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024

更新的2023-2024 (单价XBB.1.5) 新型冠状病毒肺炎接种SARS-CoV-2 Omicron XBB和BA.2.86/JN.1的有效性谱系住院和临床严重程度的比较-IVY Network,26家医院,2023年10月18日-2024 3月9日

2024-08-069
OA